Multicenter Clinical Trial of a Phakic Implantable Collamer® Lens (ICL)

NACompletedINTERVENTIONAL
Enrollment

327

Participants

Timeline

Start Date

January 30, 2020

Primary Completion Date

April 5, 2021

Study Completion Date

December 15, 2023

Conditions
MyopiaMyopic Astigmatism
Interventions
DEVICE

EVO/EVO+ Visian ICL

The investigational lenses are intended to be implanted within the posterior chamber, directly behind the iris, and in front of the anterior capsule of the human crystalline lens.

Trial Locations (14)

19406

Kremer Eye Center, King of Prussia

20716

Solomon Eye Physicians and Surgeons/Bowie Vision Institute, Bowie

44141

Cleveland Eye Clinic, Brecksville

46260

Price Vision Group,, Indianapolis

57108

Vance Thompson Vision, Sioux Falls

63141

Brinton Vision, St Louis

66210

Durrie Vision, Overland Park

68118

Kugler Vision, PC, Omaha

75243

Key-Whitman Eye Center, Dallas

78229

Parkhurst NuVision, San Antonio

84020

Hoopes Vision/Hoopes, Durrie, Rivera Research, Draper

84107

The Eye Institute of Utah, Salt Lake City

85106

Barnett Dulaney Perkins, Phoenix

96814

Aloha Laser Vision, LLC, Honolulu

All Listed Sponsors
lead

Staar Surgical Company

INDUSTRY

NCT04283149 - Multicenter Clinical Trial of a Phakic Implantable Collamer® Lens (ICL) | Biotech Hunter | Biotech Hunter